Effects of repeated anaesthesia with ketamine/medetomidine and of pre-anaesthetic administration of buprenorphine in rats

Lab Anim. 2000 Apr;34(2):207-11. doi: 10.1258/002367700780457536.

Abstract

Two groups of rats were anaesthetized at weekly intervals for 6 weeks with either ketamine/medetomidine alone (60 mg/0.4 mg/kg i.p.) or ketamine/medetomidine (45 mg/0.3 mg/kg i.p.) one hour following buprenorphine (0.05 mg/kg s.c.). Animals that received buprenorphine had longer periods of surgical anaesthesia (P = 0.04) and a greater depression of both mean pedal withdrawal score (P < 0.01) and mean respiratory rate (P = 0.014). Mean total duration of anaesthesia was also greater in the buprenorphine group on day 1. Sleep times reduced with successive doses of anaesthetic in the buprenorphine group (P = 0.024). Two animals in the buprenorphine group died. Repeated anaesthesia with ketamine/medetomidine alone was not associated with anaesthetic mortality. These results indicate that although buprenorphine has a clear anaesthetic-sparing effect, its use with ketamine/medetomidine may be associated with an increased risk of anaesthetic-related mortality.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia / veterinary*
  • Animals
  • Buprenorphine / administration & dosage*
  • Buprenorphine / adverse effects*
  • Ketamine / administration & dosage*
  • Male
  • Medetomidine / administration & dosage*
  • Preanesthetic Medication*
  • Rats
  • Rats, Wistar
  • Respiration
  • Sleep

Substances

  • Buprenorphine
  • Ketamine
  • Medetomidine